MKI67 and prostate cancer: Tumors with CAM2KN1 knockdown have reduced expression of p21, Bax and increased AR, pAKTser473, PSA, Bcl-2 and Ki67 expression, suggesting that reduction of CAM2KN1 promotes growth in AR positive prostate cancer cells.